Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Frequently asked questions
What sector does Treace Medical Concepts, Inc. Common Stock (TMCI) operate in?
Treace Medical Concepts, Inc. Common Stock belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Treace Medical Concepts, Inc. Common Stock (TMCI) current stock price?
As of the latest data, Treace Medical Concepts, Inc. Common Stock stock price is $4.42, with a previous close of $4.27. Treace Medical Concepts, Inc. Common Stock gained $0.15 in the last trading session, representing a 3.51% increase.
What is Treace Medical Concepts, Inc. Common Stock (TMCI) current market capitalization?
Treace Medical Concepts, Inc. Common Stock market cap is approximately 287.45 million.
What is Treace Medical Concepts, Inc. Common Stock (TMCI) Earnings Per Share (EPS)?
The trailing EPS is -$0.90, and the forward EPS is -$0.85.
What is Treace Medical Concepts, Inc. Common Stock (TMCI) EBITDA?
Treace Medical Concepts, Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -12.42 million.
Does Treace Medical Concepts, Inc. Common Stock (TMCI) pay dividends?
No. Treace Medical Concepts, Inc. Common Stock does not pay a dividend.
How did Treace Medical Concepts, Inc. Common Stock (TMCI) perform in its most recent earnings report?
In the last report (June 30, 2026), Treace Medical Concepts, Inc. Common Stock posted an EPS surprise of 20% and a revenue surprise of 3.3%.
When is Treace Medical Concepts, Inc. Common Stock (TMCI) next earnings report?
Treace Medical Concepts, Inc. Common Stock is expected to release its next earnings report on September 30, 2026.
What is Treace Medical Concepts, Inc. Common Stock (TMCI) beta (volatility) score?
Treace Medical Concepts, Inc. Common Stock has a beta of 1.486, suggesting it is more volatile than the market.
